Congratulations to Dr. Carlos Morales, who has been awarded the prestigious Domingo Sarmiento Distinction by the Senate of Argentina for his contributions to medical science.
Women scientists and clinicians are creators and changemakers, expanding the boundaries of human knowledge
The Neuro has launched Neuro XXceptional - an exciting new year-long video series featuring women who tell us what drove them to become scientists and clinicians, and what they love about their work. At The Neuro, these exceptional professionals are improving the lives of patients, helping us understand how the brain works and how to treat neurological disease.
Canadian Open Neuroscience Platform will make disseminating and publishing data easier
Modern neuroscience research can produce massive amounts of data, which researchers can use to find patterns revealing anything from the first physiological signs of Alzheimer’s disease to a new drug target that could stop neurodegeneration. However, this data must be stored, processed, and distributed effectively.
Message posted on behalf of the Faculty of Medicine
Starting Monday February 12th, 2018, the opening hours for the McIntyre Medical Building 3rd floor study space will be extended weekly at night until 20:30 from Monday to Thursday ONLY.
The opening hours are as follows:
- Monday to Thursday from 09:00 to 20:30
- Friday from 09:00 to 17:00
Volume in brain region linked to physiological changes characteristic of AD
New research has drawn a link between changes in the brain’s anatomy and biomarkers that are known to appear at the earliest stages of Alzheimer’s disease (AD), findings that could one day provide a sensitive but non-invasive test for AD before cognitive symptoms appear.
NeuroSGC created to increase volume and quality of cell assays for drug discovery
A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.
The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.
Industry and academia team up for the benefit of people suffering from ALS
A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.
The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.
Brain stimulation can change how much we enjoy and value music
Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.
The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.
A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.
A Brilliant Night has donated a total of $1.6 million since 2015
A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.
Research shows how the brain’s motor signals sharpen our ability to decipher complex sound flows
Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.
Discovery points to possible target for cancer drugs
McGill University researchers have discovered a mechanism through which mitochondria, the energy factory of our body’s cells, play a role in preventing cells from dying when the cells are deprived of nutrients – a finding that points to a potential target for next-generation cancer drugs.
The research, published in Molecular Cell, builds on previous work by McGill professor Nahum Sonenberg, one of the senior authors of the new study.
Research symposium, public education event and ALS walk planned
Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.
Society recognizes scholarly, research and artistic excellence.
Congratulations to Dr. Edith Hamel and Dr. Robert Zatorre, who have been elected Fellows of the Royal Society of Canada. Election to the academies of the Royal Society of Canada is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.
The Neuro to launch open research publishing platform with F1000
A new partnership between The Neuro and F1000 will create a publishing platform for researchers that will speed the progress of neuroscience discovery.
The Montreal Neurological Institute and Hospital of McGill University (The Neuro) is partnering with F1000, a provider of support services for researchers, institutes and funders, to create a new open research publishing platform called MNI Open Research (https://mniopenresearch.org).